The Global Necrotising Enterocolitis Market is witnessing increasing prevalence of pre-term births due to technological advancements

Necrotising enterocolitis (NEC) is a devastating intestinal disease that affects premature infants. It occurs when portions of the intestine undergo tissue death. The exact causes of NEC are unknown but it is associated with an immature immune system in premature infants, as well as intestinal bacteria. Symptoms may include swelling of the abdomen, bloody stools, vomiting, and lack of energy and appetite.

The global necrotising enterocolitis market is driven by the rising preterm birth rates around the world owing to increasing use of assisted reproductive technology and increasing maternal age. Other factors such as improved neonatal intensive care, growing awareness among people, and technological advancements in treatment options also contribute to the growth of this market.

The Global Necrotising Enterocolitis Market is estimated to be valued at USD 7.10 Billion in 2024 and is expected to reach USD 10.41 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.6% from 2024 to 2031.

Key Takeaways
- Key players operating in the necrotising enterocolitis market are Abbott, Becton, Dickinson and Company, Danone, Fresenius Kabi AG, and Nestle.
- Rising preterm birth rates across the world has increased the risk of NEC, driving the demand for diagnosis and treatment measures.
- Major market players are focusing on expanding their presence globally, especially in developing regions, to tap the growth opportunities.

Market Key Trends
One of the major Necrotising Enterocolitis Market Trends is the increasing research and development activities for early diagnosis. Researchers are working on identifying biomarkers in stool, blood, and tissues that can help detect NEC at earlier stages for timely intervention. Various non-invasive diagnostic techniques such as abdominal ultrasonography and magnetic resonance imaging are also being studied. This growing focus on early detection is expected to positively impact market growth.

Porter's Analysis

Threat of new entrants: Low as it needs high capital investment and strong distribution network to enter the NEC market. Existing major players have stronghold over distribution and healthcare setup.

Bargaining power of buyers: Moderate as big hospitals and healthcare providers can negotiate on price with manufacturers due to their high purchase volume.

Bargaining power of suppliers: Low due to availability of substitute components from different suppliers and suppliers are small in number compared to buyers.

Threat of new substitutes: Low at present as there are limited treatment options available for NEC. Research for developing new drugs and treatment may increase substitute threat over long term.

Competitive rivalry: High as major players compete on basis of quality, service, distribution, brand and price. They spend huge amounts on R&D and product development to maintain competitive edge.

North America currently accounts for the largest share of the NEC market in terms of value mainly due to high awareness levels regarding NEC and strong healthcare infrastructure in the region. The availability of advanced treatment options and high healthcare spending also contribute to North America’s dominance. Asia Pacific is poised to be the fastest growing market for NEC given growing incidences, improving medical facilities and rising healthcare investments in emerging countries such as China and India.

Geographical Regions

North America currently accounts for the largest share of the global NEC market in terms of value. Factors such as high awareness levels regarding NEC, presence of advanced healthcare infrastructure, rising healthcare spending and availability of technologically advanced treatment options have made North America the dominant market. The United States represents the major share within the North American market.

Asia Pacific region is anticipated to witness the fastest growth in the NEC market over the forecast period owing to rapidly growing incidences of NEC cases, improving healthcare facilities and rising healthcare investments in emerging Asian countries such as China and India. Growing medical tourism and increasing focus of major players on expanding in Asia Pacific region further complement the market growth.

Get this Report in Japanese Language:  壊死性腸炎市場

Get this Report in Korean Language:  괴사성장염시장

 About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)